The content on this site is intended for healthcare professionals only
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
NICE recommends abemaciclib in combination with endocrine therapy for adjuvant treatment of HR+/HER2...
Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers
Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy
ASCO 2022: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cance...
ASCO 2022: Novel antibody-drug conjugate doubles progression-free survival in metastatic breast canc...
ASCO 2022: ASCO & WHO to collaborate on quality indicators for cancer facilities worldwide
ASCO 2022: Novel agent increases PFS for patients with the most common type of advanced breast cance...
Ultrasound-guided microbubbles boost immunotherapy efficacy
The paired perils of breast cancer and diabetes
ECOG-ACRIN research highlights at ASCO 2022